Latest Schedule 13G passive stakes

Adage Capital Management, L.P. and associated entities have amended their Schedule 13G filing to report beneficial ownership of 6.81% of Tenax Therapeutics, Inc. common stock.

Adage Capital Management, L.P. has reported a beneficial ownership of 8.43% in Cabaletta Bio, Inc., including shares issuable upon warrant exercise.

Adage Capital Management, L.P., along with its principals Robert Atchinson and Phillip Gross, has disclosed beneficial ownership of 995,201 shares, representing 3.18% of Monro, Inc.'s common stock.

Adage Capital Management, L.P. and associated individuals have filed a Schedule 13G, reporting beneficial ownership of 1,440,000 Class A Ordinary Shares, representing 8.23% of Patriot Acquisition Corp.

Adage Capital Management, L.P. and associated entities have disclosed a beneficial ownership of 4.76% in Monopar Therapeutics Inc., including shares issuable from warrants.

Adage Capital Management, L.P. and its principals have filed a Schedule 13G, reporting beneficial ownership of 3.41% of Bright Minds Biosciences Inc. common shares.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 5.68% of Oceanhawk Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

Adage Capital Management, L.P. and its principals have reported beneficial ownership of 3.72% of Bleichroeder Acquisition Corp. II's Class A Ordinary Shares as of June 30, 2026.

Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, has reported beneficial ownership of 1,350,000 Class A Ordinary Shares, representing 7.83% of Long Table Growth Corp.

Adage Capital Management, L.P. and associated entities have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a 6.78% stake.

Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, has reported beneficial ownership of 7.75% of KPET Ultra Paceline Corporation's Class A Ordinary Shares.

Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross have filed a joint filing agreement concerning their beneficial ownership of Irenic Acquisition Corp. Class A Ordinary Shares.

Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, has reported beneficial ownership of 8.49% of Iron Dome Acquisition I Corp.'s Class A Ordinary Shares.

Adage Capital Management, L.P. has reported beneficial ownership of 8.44% of Aura Biosciences, Inc. common stock, including shares issuable upon warrant exercise.

Adage Capital Management, L.P. and associated entities have reported beneficial ownership of 4.00% of Inovio Pharmaceuticals, Inc. common stock, primarily through exercisable warrants.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 4.22% of Inflection Point Acquisition Corp. VI's Class A Ordinary Shares.

Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, have filed a Schedule 13G, reporting beneficial ownership of 5.64% of AmperCap Acquisition Company's ordinary shares.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 7.78% of Gores Holdings XI, Inc.'s Class A Ordinary Shares.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 5.71% of EyePoint, Inc.'s common stock as of June 30, 2026.

Adage Capital Management, L.P. and associated individuals have reported beneficial ownership of 5,600,000 shares, representing 3.44% of Tango Therapeutics, Inc. common stock.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 7.65% of General Catalyst Global Resilience Merger Corp.'s Class A Ordinary Shares as of June 30, 2026.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 8.20% of ACP Holdings Acquisition Corp.'s Class A Ordinary Shares.

Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, has reported beneficial ownership of 7.96% of Snow Rothschild Acquisition Corp.'s Class A Ordinary Shares.

Davis Selected Advisers has reported a beneficial ownership of 9.3% in MGM Resorts International as of June 30, 2026.

Adage Capital Management, L.P. has disclosed a beneficial ownership of 730,000 shares, representing 4.79% of Traws Pharma, Inc.'s common stock, as of June 30, 2026.

Adage Capital Management, L.P. and associated individuals have reported beneficial ownership of 700,000 shares, representing 3.42% of Forte Biosciences, Inc. common stock.

Davis Selected Advisers has updated its Schedule 13G filing, reporting beneficial ownership of 75,232,254 shares, representing 6.5% of Viatris Inc.'s common stock.

Bank of Montreal and its affiliates have filed a Schedule 13G, reporting a combined beneficial ownership of 3.38% in TC Energy Corp. common shares as of June 30, 2026.

Bank of Montreal and its affiliates have filed a Schedule 13G, reporting a combined beneficial ownership of 3.38% in TC Energy Corp. common shares as of June 30, 2026.

Curtis C. Griffith has increased his beneficial ownership of South Plains Financial, Inc. common stock to 6.15%, holding over 1.16 million shares.